Elective course in MSc Chemistry and MSc Life Science and Technology
BSc MST or LST.
The course introduces to the principles of chemical immunology. The course discusses recent advances in the field of immunology to which chemistry and chemical biology are making a significant contribution. The course will first discuss the production and use of antibodies to treat disease and the chemical modifications of antibodies to attach drugs and other cargos to them. The second major topic will be the recent developments in in immune therapies and the novel ways in which the immune system can be harnessed to fight cancer. The final topics are vaccine design and therapeutic strategies for immune dampening. Overall, the aim of the course is to make students familiar with frontline chemical immunology. Due to the fast moving nature of the field, the course will be taught as a combination of lectures as well as the discussion of recent literature. The student is expected to develop the ability to critically assess primary literature sources.
At the end of the course students:
will have knowledge of fundamental principles of immunology;
will have knowledge of antibody therapeutic production, methods of action and applications of these therapeutic agents;
will have knowledge of cancer immune therapies, such as checkpoint inhibitors, T-cell therapies, T-cell chimera
will have knowledge of the essential components of both prophylactic and therapeutic vaccines
will understand the concept in immuno-modulation and auto-immunity
will have developed the ability to read and assess primary chemical immunology literature
Mode of instruction
Lectures and assessment of recent literature.
Schedule information can be found on the website of the programmes:
The course is based on the following book: Janeway’s Immunobiology 9th edition.
Slides presented during the courses
Articles discussed and cited during the course
Final written exam (100%)
Register for this course via uSis